Cellply

Cellply is a life-science company focused on developing next-generation analytical tools enabling a deep characterization cancer immunotherapies, cell therapies and cell-based biotherapeutics. Our goal is to support the development of novel cancer immunotherapies by accelerating the R&D, advancing the quality control and monitoring the clinical response to these treatments. Through the use of proprietary microfluidic technologies, highly-automated analytical instruments and AI-powered image and data analytics, the Cellply platform defines the function of the immune system one cell at a time, combining functional data with other multiplex data and providing an unprecedented single-cell analytical solution

Microsystems,cell analysis,drug testing,cell therapy,immunotherapy,single-cell,potency,and cell function

Cellply operates in the Biotechnology research industry.

Cellply's revenue is 1m - 10m

Cellply has 11 - 50 employees.